161 related articles for article (PubMed ID: 7690819)
1. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
[TBL] [Abstract][Full Text] [Related]
5. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
[TBL] [Abstract][Full Text] [Related]
6. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
[TBL] [Abstract][Full Text] [Related]
7. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
8. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.
Bieganowska K; Höllsberg P; Buckle GJ; Lim DG; Greten TF; Schneck J; Altman JD; Jacobson S; Ledis SL; Hanchard B; Chin J; Morgan O; Roth PA; Hafler DA
J Immunol; 1999 Feb; 162(3):1765-71. PubMed ID: 9973440
[TBL] [Abstract][Full Text] [Related]
9. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
11. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
12. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
13. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
Elovaara I; Utz U; Smith S; Jacobson S
J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
15. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
17. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
18. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
[TBL] [Abstract][Full Text] [Related]
19. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
[TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
